Tag: Bharat Biotech

Covaxins Phase-3 Trials Begin: Bharat Biotech
Working For Full US FDA Approval Of Covaxin: Bharat Biotech

The FDA had on Thursday recommended Ocugen, the US partner of the Indian vaccine maker, to "pursue a Biologics Licence Application (BLA) submission instead of an EUA application" and "requested additional information and data".

  • Friday, 11 June 2021
Covaxin
Bharat Biotech Supplying Covaxin To 18 States Including Odisha

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1

  • Tuesday, 11 May 2021
COVAXIN
COVID-19 Fight: Bharat Biotech Begins Covaxin Supplies To 14 States

Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.

  • Tuesday, 11 May 2021
Covaxin Price Slashed To Rs 400/Dose For States
Covaxin Price Slashed To Rs 400/Dose For States

Bhubaneswar: A day after Serum Institute of India reduced Covishield vaccine price for States to Rs 300 per dose as a philanthropic gesture, Bharat Biotech also slashed the price of…

  • Thursday, 29 April 2021
COVID19 Vaccine: Covaxin Price Fixed At Rs 600 For States, Rs 1,200 For Pvt Hospitals
COVID19 Vaccine: Covaxin Price Fixed At Rs 600 For States, Rs 1,200 For Pvt Hospitals

New Delhi: Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage. The Hyderabad-based vaccine major also said that it would…

  • Saturday, 24 April 2021
Coronavirus
Faster Jabs, Surveillance Can Only Tame Triple-Mutant Indian Virus

New Delhi: Increasing efforts towards faster mass vaccination and virus surveillance is the key to ward off dangers posed by a triple-mutant coronavirus now present in the country, health experts…

  • Wednesday, 21 April 2021
Vaccine
Govt To Provide Rs 4,500 Cr Booster To Vaccine Manufacturers For Ramping Up Capacity

New Delhi: Looking to ramp up supplies ahead of the opening of Covid-19 vaccination to all citizens over 18 years of age, the government has approved a payment of about…

  • Tuesday, 20 April 2021
Coronavirus-Vaccine
ICMR partners with Bharat Biotech to develop COVID-19 vaccine

New Delhi: The Indian Council of Medical Research (ICMR) on Saturday partnered with Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for coronavirus. According to a statement issued by the ICMR, the team will use the virus strain isolated at ICMR’s National Institute of Virology (NIV) in Pune. “The strain has been […]

  • Saturday, 17 April 2021
Covaxin
COVAXIN-India’s 1st COVID-19 Vaccine Candidate Gets DCGI Nod For Human Trials

Hyderabad: Bharat Biotech, has successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level […]

  • Thursday, 15 April 2021
Covaxin
COVID Vaccine: Bharat Biotech Begins Human Trial Of Covaxin In India

Chandigarh: The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. In his tweet, the minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. “Human trial with Corona vaccine (COVAXIN) […]

  • Thursday, 15 April 2021
COVID19 Vaccine in India
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine

New Delhi: At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological […]

  • Wednesday, 14 April 2021
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax

Hyderabad: The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday. The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin. Joint Drugs Controller Dr S. Eswara Reddy […]

  • Monday, 12 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
COVID-19 Vaccine: Animal Study Proved Vax's Efficacy, Says Bharat Biotech

Hyderabad: Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model. “Bharat Biotech proudly announces the animal study results of COVAXIN – These results demonstrate the protective efficacy in […]

  • Monday, 12 April 2021
bharat-biotech
COVID-19 Vaccine: Bharat Biotech Inks Deal With Washington Varsity For Intranasal Vax

Hyderabad: Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19. The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA, Japan and Europe. While the Phase I trials will […]

  • Monday, 12 April 2021
Bharat Biotech, Washington Varsity Developing Intranasal Vaccine For Covid: Union Health Min
Bharat Biotech, Washington Varsity Developing Intranasal Vaccine For Covid: Union Health Min

New Delhi: Union Health Minister Harsh Vardhan on Sunday informed that Bharat Biotech will develop an intranasal vaccine for Sars-CoV-2, the virus that causes Covid-19. The minister said that the Hyderabad-based drugs and vaccine research and manufacturing company has entered into an agreement with Washington University and St. Louis University for the trials of the […]

  • Sunday, 11 April 2021
scrollToTop